Label: ODYNIA-R REGULAR- lidocaine, menthol patch

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated May 14, 2015

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Active Ingredient

    Lidocaine 4 %

    Menthol  1 %


  • PURPOSE

    Purpose

    Topical Analgesic

    External Analgesic

  • INDICATIONS & USAGE

    Uses temporarily relieves minor aches and pains associated with:  -arthritis  -simple backache --bursitis  --tendonitis

    --muscle strains --sprains  --bruises  --cramps

  • WARNINGS

    Warnings

    For external use only

    When using this product -use only as directed  -do not bandage tightly or use with a heating pad

    -avoid contact with eyes and mucus membranes  -do not apply to wounds or damaged, broken or irritated skin

  • STOP USE

    Stop use and ask a doctor if  -condition worsens  -redness is present  -irritation develops

    -symptoms persist for more than 7 days or clear up and occur again within a few days

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast feeding, ask a health professional before use

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away

  • DOSAGE & ADMINISTRATION

    Directions

    adults and children over 12 years:

    -remove backing from patch by firmly grasping both ends and gently pulling until backing separates in middle

    -carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area

    -once exposed portion of patch is positioned, carefully remove remaining backing to completely

    apply patch to affected area

    -wear one Icy Hot Patch up to 8 hours

    -repeat as necessary, but no more than 3 times daily

    children under 12 years or younger:  ask a doctor

  • INACTIVE INGREDIENT

    Inactive ingredients  aluminum hydroxide, carmellose sodium, glycerin, isopropyl myristate, methyl

    acrylate / 2 -ethylhexyl acrylate copolymer, nonoxynol-30, polyacryic acid, polysorbate 80, sodium polyacrylate, sorbitan

    sesquioleate, starch / acrylic acid graft copolymer sodium salt, talc, tartaric acid, titanium dioxide, water

  • PRINCIPAL DISPLAY PANEL

    copy of label

  • INGREDIENTS AND APPEARANCE
    ODYNIA-R  REGULAR
    lidocaine, menthol patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69647-001
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE4 g  in 100 g
    MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL1 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
    CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM (UNII: K679OBS311)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
    METHYL ACRYLATE (UNII: WC487PR91H)  
    2-ETHYLHEXYL ACRYLATE (UNII: HR49R9S6XG)  
    NONOXYNOL-30 (UNII: JJX07DG188)  
    POLYACRYLIC ACID (250000 MW) (UNII: 9G2MAD7J6W)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)  
    SORBITAN SESQUIOLEATE (UNII: 0W8RRI5W5A)  
    ACRYLIC ACID (UNII: J94PBK7X8S)  
    SODIUM (UNII: 9NEZ333N27)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    TALC (UNII: 7SEV7J4R1U)  
    TARTARIC ACID (UNII: W4888I119H)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69647-001-0115 in 1 BOX
    110 g in 1 PATCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart34803/12/2015
    Labeler - Ursh Pharmaceutical Inc. (079715344)